| Literature DB >> 35025031 |
Shujaat Hussain1,2,3,4,5, Jianshu Dong6,7,8,9,10, Xinli Ma11, Jian Li11, Shen Chen1,2,3,4,5, Agboybor Clement1,2,3,4,5, Hongmin Liu1,2,3,4,5.
Abstract
The F-box proteins (FBP), substrate recognition subunit of the SCF (Skp1-Cullin1-F-box protein complex) E3 ligase, play important roles in the ubiquitylation and subsequent degradation of the target proteins from several cellular processes. Disorders of F-box protein-mediated proteolysis lead to human malignancies. FBP plays an important role in many cellular processes, including cell proliferation, cell cycle, apoptosis, migration, invasion, and metastasis, suggesting that it can be associated with tumorigenesis, cancer development and progression. However, the expression and function of FBXO9 (F-box only protein 9) differ in various types of human cancer. Due to the ability to regulate the stability and activity of oncogenes and tumor-suppressor genes, and the physiological functions of many of the F-box proteins remain subtle, further genetic and mechanistic studies will elaborate and help define FBXO9's role. Targeting F-box protein or F-box protein signaling pathways could be an effective strategy for preventing or treating human cancer. This review is presented to summarize the part of FBXO9 in different types of human cancer and its regulation mechanism, and to pave the way to design FBXO9-targeting anticancer therapies.Entities:
Keywords: E3 ubiquitin ligase; F-box only protein 9; F-box protein; Tumorigenesis; Ubiquitination
Mesh:
Substances:
Year: 2022 PMID: 35025031 DOI: 10.1007/s11033-021-07057-7
Source DB: PubMed Journal: Mol Biol Rep ISSN: 0301-4851 Impact factor: 2.316